CASI Pharmaceuticals CASIF
OTC CASIF
$0.13 +0.00 (+0.00%)
At close: Sep 28, 2026 · 4:00 PM EDT

CASI Pharmaceuticals (CASIF) Total Debt (2024 - 2026)

Updated

CASI Pharmaceuticals' Total Debt came in at $21.25 million for Q2 2026, up 13.5% from $18.73 million a year earlier.

Analysis

CASI Pharmaceuticals (CASIF) Total Debt (2024 - 2026) Analysis & Trends

At the end of FY2025, CASI Pharmaceuticals' Total Debt was $20.19 million, up 9.8% from FY2024.

  • Going back by year, Total Debt was $18.39 million in FY2024.
  • The Q2 2026 figure represents the highest quarterly Total Debt in data going back to Q1 2024.
  • Year-over-year, Total Debt increased in three of the last four quarters, with growth averaging 6.1%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 49.04 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 70.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 53.91 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 37.49 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -111.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 57.30 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 26.25 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 63.19 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 CASI Pharmaceuticals 2.67 Mn -18.15 Mn - 21.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21.25 Mn
Dec 31, 2025 20.19 Mn
Sep 30, 2025 18.86 Mn
Jun 30, 2025 18.73 Mn
Mar 31, 2025 18.49 Mn
Dec 31, 2024 18.39 Mn
Jun 30, 2024 18.47 Mn
Mar 31, 2024 18.59 Mn
API Access

CASI Pharmaceuticals Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=CASIF&period=max&api_key=YOUR_API_KEY